Am J Gastroenterol

1. KAMBOJ AK, Goyal R, Vantanasiri K, Sachdeva K, et al
   Clinical Outcomes After Endoscopic Management of Low-Risk and High-Risk T1a Esophageal Adenocarcinoma: A Multicenter Study.
   Am J Gastroenterol. 2024;119:662-670.
   

   >> Share

   
   

   
   Am J Ophthalmol

2. ZHANG Y, Zhao H
   HIV-Associated Meibomian Gland Adenoma With Atypical Hyperplasia.
   Am J Ophthalmol. 2024;260:e1-e2.
   

   >> Share

   
   

   
   Am J Surg

3. LEONG D, Leslie C, Laurie B, Hou L, et al
   Tumour size predicts risk of recurrence in tall cell subtype papillary thyroid carcinoma.
   Am J Surg. 2024 Mar 26:S0002-9610(24)00184-3. doi: 10.1016/j.amjsurg.2024.
   

   >> Share

   
   

   
   Ann Surg

4. HENCKENS SP, Schuring N, Elliott JA, Johar A, et al
   Recurrence and Survival after Minimally Invasive and Open Esophagectomy for Esophageal Cancer - A Post Hoc Analysis of the Ensure Study.
   Ann Surg. 2024 Apr 5. doi: 10.1097/SLA.0000000000006280.
   

   >> Share

   
   

   
   BMC Cancer

5. AVRY F, Roseau C, Leguay Z, Brabant S, et al
   Evaluation of a new score associated with acute kidney injury in patients treated with cisplatin based EXTREME regimen.
   BMC Cancer. 2024;24:405.
   

   >> Share

   
   
6. KRIELLAARS Y, Vermaire JA, Beugeling M, Poorter R, et al
   The effect of physical exercise during radiotherapy on physical performance in patients with head and neck cancer: a trial within cohorts study protocol, the vital study.
   BMC Cancer. 2024;24:403.
   

   >> Share

   
   
7. CUI C, Wang L, Wang X
   Effects of physical and psychological symptoms on cancer-related fatigue among esophageal cancer patients.
   BMC Cancer. 2024;24:398.
   

   >> Share

   
   
8. CHEN W, Lin G, Chen Y, Cheng F, et al
   Prediction of the Ki-67 expression level in head and neck squamous cell carcinoma with machine learning-based multiparametric MRI radiomics: a multicenter study.
   BMC Cancer. 2024;24:418.
   

   >> Share

   
   
9. LI J, Gao X, Sun X, Li H, et al
   Investigating the causal role of the gut microbiota in esophageal cancer and its subtypes: a two-sample Mendelian randomization study.
   BMC Cancer. 2024;24:416.
   

   >> Share

   
   

   
   Clin Cancer Res

10. READ ML, Brookes K, Zha L, Manivannan S, et al
    Combined Vorinostat and Chloroquine Inhibit Sodium-Iodide Symporter Endocytosis and Enhance Radionuclide Uptake In Vivo.
    Clin Cancer Res. 2024;30:1352-1366.
    

    >> Share

    
    
11. EARLAND N, Semenkovich NP, Ramirez RJ, Gerndt SP, et al
    Sensitive MRD Detection from Lymphatic Fluid after Surgery in HPV-Associated Oropharyngeal Cancer.
    Clin Cancer Res. 2024;30:1409-1421.
    

    >> Share

    
    
12. LECHNER MG, Brent GA
    A New Twist on a Classic: Enhancing Radioiodine Uptake in Advanced Thyroid Cancer.
    Clin Cancer Res. 2024 Jan 10. doi: 10.1158/1078-0432.CCR-23-3503.
    

    >> Share

    
    
13. SHANNON NB, Iyer NG
    Unveiling Liquid Gold: Lymph as an HPV Marker in OPSCC to Guide Treatment Decisions.
    Clin Cancer Res. 2024;30:1223-1225.
    

    >> Share

    
    

    
    Dis Esophagus

14. YUNRONG T, Jin WW, Mahendran HA, Koon YB, et al
    Pre-operative psoas muscle index, a surrogate for sarcopenia; as a predictor of post-esophagectomy complications.
    Dis Esophagus. 2024;37:doad072.
    

    >> Share

    
    
15. PEI S, Huang JQ, Liang HW, Liu Y, et al
    Adjuvant treatment patterns for pT3N0M0 esophageal cancer undergoing surgery.
    Dis Esophagus. 2024 Mar 28:doae026. doi: 10.1093.
    

    >> Share

    
    
16. FURUE Y, Yoda Y, Hori K, Nakajo K, et al
    Outcomes of repeated endoscopic submucosal dissection for superficial Esophageal squamous cell carcinoma on endoscopic resection scar.
    Dis Esophagus. 2024 Mar 28:doae018. doi: 10.1093.
    

    >> Share

    
    
17. ZHANG GL, Zhu QK, Ma TY, Weng CG, et al
    Clinical study of camrelizumab combined with docetaxel and carboplatin as a neoadjuvant treatment for locally advanced oesophageal squamous cell carcinoma.
    Dis Esophagus. 2024;37:doad073.
    

    >> Share

    
    

    
    Int J Cancer

18. CHARTERS E, Cheng K, Dunn M, Heng C, et al
    Restorabite: Phase II trial of jaw stretching exercises using a novel device for patients with trismus following head and neck cancer.
    Int J Cancer. 2024 Mar 31. doi: 10.1002/ijc.34941.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

19. HIROSE K, Sato M
    Clinical Results and Prognostic Factors in BNCT for Recurrent Squamous Cell Carcinoma of the Head and Neck under the Japan National Health Insurance System: A Retrospective Study of the Initial 47 Patients.
    Int J Radiat Oncol Biol Phys. 2024 Apr 3:S0360-3016(24)00466.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

20. SAKO A, Matsuse M, Saenko V, Tanaka A, et al
    TERT promoter mutations increase tumor aggressiveness by altering TERT mRNA splicing in papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2024 Apr 5:dgae220. doi: 10.1210.
    

    >> Share

    
    

    
    J Nucl Med

21. GREENSPAN BS, Hofman MS, Buscombe J
    The Accomplishments and Legacy of Saul Hertz, MD.
    J Nucl Med. 2024;65:659-663.
    

    >> Share

    
    
22. LEUNG KH, Rowe SP, Sadaghiani MS, Leal JP, et al
    Deep Semisupervised Transfer Learning for Fully Automated Whole-Body Tumor Quantification and Prognosis of Cancer on PET/CT.
    J Nucl Med. 2024 Feb 29:jnumed.123.267048. doi: 10.2967/jnumed.123.267048.
    

    >> Share

    
    

    
    Oral Oncol

23. LORINI L, Gili R, Salvestrini V, Morelli I, et al
    De novo metastatic head and neck squamous cell carcinoma: Why does locoregional control "always" matter?
    Oral Oncol. 2024;152:106768.
    

    >> Share

    
    
24. MEGAHED R, Prabhu AV, Mack DP, Gholami S, et al
    Re-irradiation of recurrent head and neck cancers using pulsed reduced dose rate radiotherapy: An institutional series.
    Oral Oncol. 2024;152:106778.
    

    >> Share

    
    
25. XIAO X, Shi Z, Song Z
    Comment on circulatory mitochondrial DNA as a novel biomarker for head and neck cancers.
    Oral Oncol. 2024;152:106785.
    

    >> Share

    
    
26. DAS R, Misra SR, Nayak A
    Awareness regarding oral cancer amongst the dental, medical, and nursing students: Is something lacking?
    Oral Oncol. 2024;152:106790.
    

    >> Share

    
    
27. ARAGAO HHR, Monteiro MA, Lopes NVA, Cunha JLS, et al
    Comment on "Betel-nut chewing does not influence PD-L1 expression rates in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC): A prospective biomarker prevalence study".
    Oral Oncol. 2024;152:106788.
    

    >> Share

    
    
28. SARAVANAN M
    Comment on "The microbiome and oral cancer: More questions than answers".
    Oral Oncol. 2024;152:106792.
    

    >> Share

    
    

    
    PLoS One

29. JIN X, Yin Z, Li X, Guo H, et al
    TIM3 activates the ERK1/2 pathway to promote invasion and migration of thyroid tumors.
    PLoS One. 2024;19:e0297695.
    

    >> Share

    
    
30. PAO TH, Chen YY, Chang WL, Wu SY, et al
    Lymph node volume predicts survival in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery.
    PLoS One. 2024;19:e0300173.
    

    >> Share

    
    

    
    Radiology

31. GEORGIADES C
    Slow Growth, Excellent Prognosis: The Treatment and Overtreatment of Papillary Thyroid Cancer.
    Radiology. 2024;311:e240207.
    

    >> Share

    
    
32. ZHAO ZL, Wang SR, Dong G, Liu Y, et al
    Microwave Ablation versus Surgical Resection for US-detected Multifocal T1N0M0 Papillary Thyroid Carcinoma: A 10-Center Study.
    Radiology. 2024;311:e230459.
    

    >> Share

    
    

    
    Surgery

33. LEE-SAXTON YJ, Palacardo F, Greenberg JA, Egan CE, et al
    Radioactive iodine administration is not associated with improved disease-specific survival in classic papillary thyroid carcinoma greater than 4 cm confined to the thyroid.
    Surgery. 2024;175:215-220.
    

    >> Share

    
    
34. WRIGHT K, Fisher JC, Rothberger GD, Prescott JD, et al
    Incidental (68)Ga-DOTATATE uptake in thyroid nodules: Is guideline-directed management still appropriate?
    Surgery. 2024;175:228-233.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share